QLIF-17. ASSESSING DEPRESSION IN GLIOMA PATIENTS

BACKGROUND: A recent Cochrane review revealed only 5 studies exploring depression in glioma patients with variable incidence of 17% to as high as 49%; and even fewer studies using instruments designed to measure depression severity and therapeutic approaches. METHODS: Patients enrolled in the Neuro-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Acquaye, Alvina A, Garren, Nancy, Vera, Elizabeth, Lisa, Boris, Siegel, Christine, Park, Deric M, Wu, Jing, Crandon, Sonja, Theeler, Brett J, Sul, Joo-Hee, Gilbert, Mark R, Armstrong, Terri
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692376/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.827
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi